Compare Lumentum (LITE) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lumentum vs Relay Therapeutics Inc. Common Stock — how do they compare? Lumentum trades at $1,103.36 (market cap $94.99B), while Relay Therapeutics Inc. Common Stock trades at $17.88 (market cap $3.82B). The key difference: Lumentum is far larger — about 24.9× Relay Therapeutics Inc. Common Stock's market cap, and Lumentum is more actively traded (4,855,776 versus 4,332,079). Which is the better fit depends on your goals — on Pluang, investors hold Lumentum for 4 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| LITE | RLAY | |
|---|---|---|
Market Cap | $94.99B | $3.82B |
Volume | 4,855,776 | 4,332,079 |
Sector | Technology | Health |
52-Week High | $1.13K | $20.75 |
52-Week Low | $149.61 | $6.03 |
Typical Hold Time | 4 Days | 0 Days |
Enterprise Value | $93.92B | $2.93B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lumentum
Lumentum develops photonic products, including optical components, transceivers, and lasers. Its technologies support data centers, communications networks, industrial manufacturing, and sensing applications.
Read more on LITE →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
